Literature DB >> 25725029

Parietal bone osteomyelitis in melioidosis.

Hariprasad Sadanand Shetty1, Ajay Raj Mallela1, Barkur Ananthakrishna Shastry2, Vasudeva Acharya2.   

Abstract

We report a case of a 55-year-old man with uncontrolled diabetes who presented with pneumonia. During his hospital stay his clinical status worsened and he had a focal seizure. MRI showed central nervous system involvement and parietal bone osteomyelitis. As the patient's blood culture and endotracheal aspirate grew Burkholderia pseudomallei, melioidosis was diagnosed. He was treated with meropenem after failure to respond to ceftazidime. He gradually improved over a period of 4 weeks and was discharged. Early diagnosis and therapy resulted in improved outcome. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25725029      PMCID： PMC4346968          DOI： 10.1136/bcr-2014-208612

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  18 in total

1.  Melioidotic osteomyelitis in northern Australia.

Authors:  I Popoff; J Nagamori; B Currie
Journal:  Aust N Z J Surg       Date:  1997-10

2.  Osteomyelitis and septic arthritis from infection with Burkholderia pseudomallei: A 20-year prospective melioidosis study from northern Australia.

Authors:  Levi P Morse; Jonathan Smith; Janak Mehta; Linda Ward; Allen C Cheng; Bart J Currie
Journal:  J Orthop       Date:  2013-05-13

3.  Halving of mortality of severe melioidosis by ceftazidime.

Authors:  N J White; D A Dance; W Chaowagul; Y Wattanagoon; V Wuthiekanun; N Pitakwatchara
Journal:  Lancet       Date:  1989-09-23       Impact factor: 79.321

4.  Melioidosis: acute and chronic disease, relapse and re-activation.

Authors:  B J Currie; D A Fisher; N M Anstey; S P Jacups
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 May-Jun       Impact factor: 2.184

5.  The epidemiology of melioidosis in Australia and Papua New Guinea.

Authors:  B J Currie; D A Fisher; D M Howard; J N Burrow; S Selvanayagam; P L Snelling; N M Anstey; M J Mayo
Journal:  Acta Trop       Date:  2000-02-05       Impact factor: 3.112

6.  Comparison of imipenem and ceftazidime as therapy for severe melioidosis.

Authors:  A J Simpson; Y Suputtamongkol; M D Smith; B J Angus; A Rajanuwong; V Wuthiekanun; P A Howe; A L Walsh; W Chaowagul; N J White
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

Review 7.  Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions.

Authors:  B J Currie
Journal:  Eur Respir J       Date:  2003-09       Impact factor: 16.671

8.  Outcomes of patients with melioidosis treated with meropenem.

Authors:  Allen C Cheng; Dale A Fisher; Nicholas M Anstey; Dianne P Stephens; Susan P Jacups; Bart J Currie
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  Recurrent melioidosis in the Darwin Prospective Melioidosis Study: improving therapies mean that relapse cases are now rare.

Authors:  Derek S Sarovich; Linda Ward; Erin P Price; Mark Mayo; Matthew C Pitman; Robert W Baird; Bart J Currie
Journal:  J Clin Microbiol       Date:  2013-11-27       Impact factor: 5.948

10.  Localised melioidotic osteomyelitis.

Authors:  T Subhadrabandhu; S Prichasuk; B Sathapatayavongs
Journal:  J Bone Joint Surg Br       Date:  1995-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.